Treating pain during pregnancy

Canadian Family Physician

Volumn 56, Issue 1, 2010, Pages 25-27

  Babb, Malaika ^b   Koren, Gideon ^a   Einarson, Adrienne ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; KETOROLAC; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PETHIDINE; TRAMADOL;

ADVERSE OUTCOME; ANALGESIC ACTIVITY; BIRTH DEFECT; BLEEDING; CANCER PAIN; CHRONIC PAIN; CONGENITAL MALFORMATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FETAL HEMORRHAGE; HUMAN; MATERNAL BLEEDING; PAIN; PREGNANCY; PREGNANCY OUTCOME; PRESCRIPTION; RISK ASSESSMENT; SHORT SURVEY; THIRD TRIMESTER PREGNANCY; WITHDRAWAL SYNDROME;

ANALGESICS; CHRONIC DISEASE; FEMALE; HUMANS; PAIN; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 75849145232     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (15)

1. Bruehl S, Chung OY, Jirjis JN, Biridepalli S. Prevalence of clinical hypertension in patients with chronic pain compared to non pain general medical patients. Clin J Pain 2005;21(2):147-53.
2. Whitten CE, Donovan M, Cristobal K. Treating chronic pain: new knowledge, more choices. Permanente J 2005;9(4):9-18. Available from: http://xnet.kp.org/ permanentejournal/fall05/pain3.html. Accessed 2006 Jan 15.
3. Rebordosa C, Kogevinas M, Bech BH, Sørensen HT, Olsen J. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes. Int J Epidemiol 2009;38(3):706-14. Epub 2009 Mar 30.
4. Werler MM, Mitchell AA, Moore CA, Honein MA. Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A 2009;149A(7):1399-406.
5. Østensen M, Förger F. Management of RA medications in pregnant patients. Nat Rev Rheumatol 2009;5(7):382-90. Epub 2009 Jun 9.
6. James AH, Brancazio LR, Price T. Aspirin and reproductive outcomes. Obstet Gynecol Surv 2008;63(1):49-57.
7. Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 2006;40(5):824-9. Epub 2006 Apr 25.
8. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group; 1977.
9. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. p. 319-20.
10. Shaw GM, Malcoe LH, Swan SH, Cummins SK, Schulman J. Congenital cardiac anomalies relative to selected maternal exposures and conditions during early pregnancy. Eur J Epidemiol 1992;8(5):757-60.
11. Khan K, Chang J. Neonatal abstinence syndrome due to codeine. Arch Dis Child Fetal Neonatal Ed 1997;76(1):F59-60.
12. Reynolds EW, Riel-Romero RM, Bada HS. Neonatal abstinence syndrome and cerebral infarction following maternal codeine use during pregnancy. Clin Pediatr (Phila) 2007;46(7):639-45.
13. Collado F, Torres LM. Association of transdermal fentanyl and oral transmucosal fentanyl citrate in the treatment of opioid naive patients with severe chronic noncancer pain. J Opioid Manag 2008;4(2):111-5.
14. Regan J, Chambers F, Gorman W, MacSullivan R. Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy. BJOG 2000;107(4):570-2.
15. Einarson A, Bozzo P, Taguchi N. Use of a fentanyl patch throughout pregnancy. J Obstet Gynaecol Can 2009;31(1):20.